Novel Coronavirus (nCoV) outbreak in the city of Wuhan, China during December 2019, has now spread to various countries across the globe triggering a heightened containment effort. This human pathogen is a member of betacoronavirus genus carrying 30 kilobase of single positive-sense RNA genome. Understanding the evolution, zoonotic transmission, and source of this novel virus would help accelerating containment and prevention efforts. The present study reported detailed analysis of 2019-nCoV genome evolution and potential candidate peptides for vaccine development. This nCoV genotype might have been evolved from a bat-CoV by accumulating non-synonymous mutations, indels, and recombination events. Structural proteins Spike (S), and Membrane (M) had extensive mutational changes, whereas Envelope (E) and Nucleocapsid (N) proteins were very conserved suggesting differential selection pressures exerted on 2019-nCoV during evolution. Interestingly, 2019-nCoV Spike protein contains a 39 nucleotide (5'-aAT GGT GTT GAA GGT TTT AAT TGT TAC TTT CCT TTA CAA Tca-3') sequence insertion, which shares homology to fish genomic sequence of Myripristis murdjan, an abundant fish type in Indo-Pacific Ocean. Furthermore, we identified eight high binding affinity (HBA) CD4 T-cell epitopes in the S, E, M and N proteins, which can be commonly recognized by HLA-DR alleles of Asia and Asia-Pacific Region population. These immunodominant epitopes can be incorporated in universal subunit CoV vaccine. Diverse HLA types and variations in the epitope binding affinity may contribute to the wide range of immunopathological outcomes of circulating virus in humans. Our findings emphasize the requirement for continuous surveillance of CoV strains in live animal markets to better understand the viral adaptation to human host and to develop practical solutions to prevent the emergence of novel pathogenic CoV strains.
INTRODUCTION
Current 2019 novel Coronavirus (2019-nCoV) outbreak in China and its subsequent spread to multiple countries across four continents precipitated a major global health crisis. Uncovering the 2019-nCoV genome evolution and immune determinants of its proteome would be crucial for outbreak containment and preventative efforts.
Coronaviruses are single positive-stranded RNA viruses belonging to Coronaviridae family 1 , which are divided into four genera: Alpha-, Beta-, Delta-and Gammacoronavirus. CoVs are commonly found in many species of animals, including bats, camels and humans. Occasionally, the animal CoVs can acquire genetic mutations by errors during genome replication or recombination mechanism, which can further expand their tropism to humans. The first human CoVs were discovered in the mid-1960s. A total of six human CoV types were identified to be responsible for causing human respiratory ailments, which include two alpha CoVs (229E; NL63), and four beta CoVs (OC43; HKU1; SARS-CoV; MERS-CoV) 2 . Typically, these CoVs cause asymptomatic infection or severe acute respiratory illness, including fever, cough, and shortness of breath. However, other symptoms such as gastroenteritis and neurological diseases of varying severity have also been reported [3] [4] [5] .
The recent two CoV human outbreaks were caused by betacoronaviruses, SARS-CoV (Severe Acute Respiratory Syndrome-CoV) and MERS-CoV (Middle East Respiratory Syndrome-CoV). In 2002, SARS-CoV outbreak was first reported in China, which spread globally causing hundreds of deaths with a 11% mortality rate. In 2012, MERS-CoV was first recognized in Saudi Arabia and subsequently in other countries, which has a fatality rate of 37%. Since December 2019, the seventh novel human betacoronavirus (2019-nCoV) causing pneumonia outbreak was reported by the World Health Organization. This novel virus is linked with an outbreak of febrile respiratory illness in the city of Wuhan, Hubei Province, China with an epidemiological association to the Huanan Seafood Wholesale Market selling live farm and wild animals 6 and elsewhere in the city 1 .
While the 2019-CoV appears to be a zoonotic infectious disease, the specific animal species and other reservoirs need to be clearly defined. Identification of the source animal species for this outbreak would facilitate global public health authorities to inspect the trading route and the movement of wild and domestic animals to Wuhan and taking control measures to limit the spread of this disease 7 . The 2019-nCoV outbreak has a fatality rate of 2% with significant impact on global health and economy. As of 29 January 2020, the 2019-nCoV has spread to fifteen countries including Asia-Pacific region (Thailand, Japan, The Republic of Korea, Malaysia, Cambodia, Sri Lanka, Nepal, Vietnam, Singapore, and Australia), United Arab Emirates, France, Germany, Canada and the United States with 6065 confirmed cases, in which 5997 reported from China 8 .
Here, we report a detailed genetic analysis of 2019-nCoV evolution based on 47 genome sequences available in Global Initiative on Sharing All Influenza Database (GISAID) (https://www.gisaid.org/) (Supplemental Table 1 ) and one genome sequence from GenBank. We further defined potential epitope targets in the structural proteins (SPs) for vaccine design.
MATERIALS AND METHODS
Phylogenetic tree construction. We employed the following methodologies for genetic analyses. The genome sequences of 2019-nCoV were obtained on 29 January 2020 along with genetically related 10 SARS-CoV/SARS-CoV-like virus genome sequences that we identified through the BLASTN search in NCBI database. We also included 10 sequences of MERS-CoV strains and one outgroup alphacoronavirus sequence. 2019-nCoV genome (30 Kb in size) codes for a large non-structural polyprotein ORF1ab that is proteolytically cleaved to generate 15/16 proteins, and four structural proteins -Spike (S), Envelope (E), Membrane (M) and Nucleocapsid (N), as well as five accessory proteins (ORF3a, ORF6, ORF7a, ORF8 and ORF10). The genome sequences were aligned using the MAFFTv7 program 9 , which were exported to MEGA-X 10 for Neighbor-Joining (NJ) phylogenetic tree construction with 1000 bootstrap support and genetic distance calculations. Structural genes/proteins were aligned with closely related sequences using Clustal Omega Program 11 .
High Binding Affinity (HBA) epitope identification. In order to identify the potential target peptides for vaccine design, the structural protein sequences of highly conserved and annotated representative 2019-nCoV strain Wuhan-Hu-1 (MN908947.3) were used to predict the CD4 T-cell epitopes (TCEs) with the Immune Epitope Database and Analysis Resource (IEDB) consensus tool by IEDB recommended prediction method 12, 13 . To identify the most immunodominant (IMD) CD4 epitopes, we employed the computational approach described previously 14 . For all the possible 15-mer peptides from the SPs, the binding affinity was predicted using six most prevalent Human Leukocyte Antigen (HLA; MHC Class-II DR) alleles (http://allelefrequencies.net/) that cover most of the ethnic population in China (PRC), Thailand (TH) and Japan (JPN) (Supplemental Table 2 ). Since, the prevalence of dominant HLA-DR types may vary in human populations from different countries, the prevalent six HLA-DR alleles covering Asia-Pacific region 14 and Global population data sets have been used for binding affinity predictions to assess the generality of those predicted epitopes with high binding affinities (HBA). We calculated the average binding affinity score for each predicted 15mer peptides against all the predominant HLA-DR types from each country/region using a sliding window approach (Figure 2 ). This approach is more efficient as the epitopes predicted with average HBA (IC <=10 nM), indicate that those epitopes are more likely to bind and enhance a cellular immune response in the studied population.
RESULTS AND DISCUSSION
Phylogenetic analysis reveals 2019-nCoV closely related to Bat CoV. Genome based phylogenetic tree analysis revealed a major cluster of large clade was formed with humans 2019-nCoV strains, SARS-CoV-like strains from bats and human SARS-clustered together with 96% bootstrap support, but separated from bat/bat-SARS like strains and human SARS-CoVs clusters, indicating that 2019-nCoV belongs to a novel genotype. A small cluster was formed by MERS-CoV strains, which was genetically unrelated to the strains circulating in the current outbreak. This result indicated that the causative agent of current 2019-2020 outbreak is a betacoronavirus that is genetically and evolutionarily related to bat CoVs: bat/Yunnan/RaTG13/2013 and bat/SARS-CoVlike-viruses. Moreover, the result suggests that the evolutionary pressures exerted on 2019-nCoV, as well as bat and human SARS-coronaviruses were different.
Interestingly, strains from the current outbreak were clearly segregated from bat SARS- (Table 1C) . Whereas, M protein shared 98.6% identity with one amino acid insertion (position 4, S) and N protein showed 99% identity with 4 non-synonymous changes (P37S, S215G, S243G, Q267A).
Envelope protein shares 100% identity.
The genome alignment between the novel and bat (bat/Yunnan/RaTG13/2013) coronaviruses showed 2 of 7 insertions (Table 1A) In summary, the present study provided a detailed genetic analysis of 2019-nCoV genome evolution and potential universal epitopes for subunit vaccine development.
This 2019-nCoV strain might be evolved from the bat-CoV by accumulating favorable genetic changes for human infection. 
SUPPLEMENTAL TABLES
Supplemental Table 1 -Summary of authors, source laboratories and metadata from GISAID for 2019-nCoV genomes analyzed in this study.
Supplemental Table 2 -Amino acid sequences of high confidence mean HBA (IC <= 10nM) CD4 T-cell epitopes from functionally important regions of the four structural proteins (S, E, M and N). The details of protein name, starting and ending positions of epitopes in the given protein, and epitope sequences are provided. The unique epitope sequences for each protein and the universal epitopes commonly recognized by HLA-DR alleles of all five population sets (highlighted in red) are listed at the end of each 
